IV Antibiotic Regimen for Hospitalized Abscess Cellulitis

Initial Assessment and Risk Stratification

The Infectious Diseases Society of America recommends assessing for systemic toxicity signs, such as fever, hypotension, tachycardia, altered mental status, or SIRS criteria, in patients with abscess cellulitis requiring hospitalization 2
Purulent drainage or exudate mandates MRSA coverage, according to the Clinical Infectious Diseases guidelines 1, 2
High-risk features, including penetrating trauma, injection drug use, known MRSA colonization, or immunocompromise, should be identified in hospitalized patients with abscess cellulitis 1, 3
Blood cultures should be obtained in hospitalized patients, particularly those with malignancy, severe systemic features, neutropenia, or severe immunodeficiency, as recommended by the Clinical Infectious Diseases guidelines 1, 2

The American College of Clinical Pharmacy recommends vancomycin 15-20 mg/kg IV every 8-12 hours as the gold standard for hospitalized patients with abscess cellulitis requiring MRSA coverage, with A-I level evidence 1, 2, 3
Linezolid 600 mg IV every 12 hours is an equally effective alternative to vancomycin, with A-I evidence, and is superior to vancomycin specifically for MRSA infections in some studies 1, 2
Daptomycin 4 mg/kg IV once daily is an alternative to vancomycin, with A-I evidence 1, 2
Clindamycin 600 mg IV every 8 hours is an alternative to vancomycin, but only if local MRSA resistance rates are <10%, with A-III evidence 1, 2

The standard duration of treatment is 5 days if clinical improvement occurs, with extension only if symptoms have not improved within this timeframe, as recommended by the Clinical Infectious Diseases guidelines 1, 2
For complicated infections requiring surgical debridement or necrotizing fasciitis, treatment should be extended to 7-14 days guided by clinical response, according to the Clinical Infectious Diseases guidelines 1, 2

The Infectious Diseases Society of America recommends never using beta-lactams alone for abscess cellulitis, as they have zero activity against MRSA 3
Abscess requires drainage as primary treatment, and antibiotics alone will fail regardless of choice, as stated in the Clinical Infectious Diseases guidelines 1
Clindamycin should not be used if local MRSA resistance exceeds 10% or if inducible resistance is detected, according to the Clinical Infectious Diseases guidelines 1, 3

Once clinical improvement is demonstrated, transition to oral antibiotics, such as TMP-SMX 1-2 double-strength tablets twice daily, doxycycline 100 mg twice daily, or clindamycin 300-450 mg three times daily (if resistance <10%), as recommended by the Praxis Medical Insights guidelines 2, 3

The American College of Clinical Pharmacy recommends elevating the affected extremity to promote drainage and hasten improvement, and treating predisposing conditions, such as tinea pedis, toe web abnormalities, venous insufficiency, and lymphedema 1, 2
Systemic corticosteroids, such as prednisone 40 mg daily for 7 days, may be considered in non-diabetic adults, though evidence is limited, according to the Praxis Medical Insights guidelines 2